Contact Us Careers Register
Coherent Market Insights

Ingestible Smart Pills Market to Reach US$ 1,734.3 Million by 2027

Discount sale is live

Ingestible Smart Pills Market to Reach US$ 1,734.3 Million by 2027 - Coherent Market Insights

Publish In : 19 Aug, 2020

Press Release ID: CMI3348

Category : Medical Devices

Smart pills are miniature electronic devices that are shaped and designed in the mold of pharmaceutical capsules. These pills are used for sensing, imaging, and drug delivery.

The global ingestible smart pills market is estimated to account for US$ 1,175.4 Mn in terms of value and is expected to reach US$ 1,734.3 Mn by the end of 2027.

Global Ingestible Smart Pills Market: Drivers

Increasing adoption of smart pills is expected to propel growth of the global ingestible smart pills market over the forecast period. For instance, in January 2020, New University of Colorado adopted etectRx, Inc.’s ID-Cap System in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication.

Global Ingestible Smart Pills Market: Opportunities

Increasing geriatric population is expected to boost demand for digital medicine, thereby offering lucrative growth opportunities for players in the global ingestible smart pills market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

Global Ingestible Smart Pills Market: Restraints

Limited coverage in terms of reimbursement is expected to hinder growth of the global ingestible smart pills market. Changes in reimbursement policies have played a crucial role in the past few years. Reimbursement for patient monitoring systems by government payer organizations and private payers is limited.  As the purpose is monitoring, there is no positive outcome from the use of these devices as per the established and scalable outcomes of treatment devices. Therefore, reimbursement for patient monitoring pills used in diagnostic devices is not provided by health insurance companies.

Key Takeaways:

The global ingestible smart pills market was valued at US$ 1,111.8 Mn in 2019 and is forecast to reach a value of US$ 1,734.3 Mn by 2027 at a CAGR of 5.7% between 2020 and 2027. Major factor driving the growth of global ingestible smart pills market during the forecast period include increasing prevalence of gastrointestinal diseases, and several benefits of ingestible smart pills.

Smart pills held dominant position in the global ingestible smart pills market in 2019, accounting for 81.7% share in terms of value, followed by workstation, respectively. Smart pills are expected to witness significant growth over the forecast period due to increasing use of smart pills in diseases diagnostics.

Market Trends

Major players in the global ingestible smart pills market are focused on adopting collaboration strategies to expand their product portfolio. For instance, in June 2019, etectRx extended its collaboration with Qualicaps to further develop the manufacturing and assembly processes for ID-Capsules and the ID-Cap System. 

Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in August 2018, PENTAX Medical, a division of the HOYA Group, acquired a controlling interest in PlasmaBiotics SAS, a manufacturer of devices for drying and storage of endoscopes.

Global Ingestible Smart Pills Market: Competitive Landscape   

Major players operating in the global ingestible smart pills market include, BodyCap Medical, Given Imaging Ltd., Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., Chongqing Jinshan Science and Component (Group) Co., Ltd., Medimetrics, IntroMedic Co., Ltd., Check-Cap Ltd., Boston Scientific Corporation, HQ Inc., Smart Pill Inc., Medtronic plc, Philips Healthcare, etectRx, Inc., Novartis, Siemens Healthcare, Pentax Medical Company (HOYA Corporation), GE Healthcare, and Stryker Corporation.

Global Ingestible Smart Pills Market: Key Developments

June 2019: etectRx Inc. announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance Monitoring System and Associated Methods.”

Segmentation

  • By Component
    • Smart Pills
      • Patient Monitoring
      • Capsule Endoscopy
        • Small Bowel Endoscopy
        • Esophagus Endoscopy
        • Colon Endoscopy
      • Workstation
    • By Application
      • Imaging
      • Monitoring
    • By End User
      • Hospitals
      • Clinics
      • Research Institutes
      • Home Healthcare

ABOUT US:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

CONTACT US:

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

PHONE:

UK: +44-203-957-8553 / +44-203-949-5508

US: +1-252-477-1362

AUS: +61-8-7924-7805

INDIA: +91-848-285-0837

Email: sales@coherentmarketinsights.com

Follow Us: LinkedIn | Twitter

Need more?

Speak to our analyst to understand how this research was put together Add more segments or countries to the scope as part of free customization Understand how this report can have a direct impact on your revenue

  • Supplier Analysis
  • Value Chain Analysis
  • Demand Analysis
  • Customer Intelligence
  • Trade Analysis
  • Pricing Analysis

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports


Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Created billion dollars of revenue impact on thousands of clients

trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Enquiry Icon Contact Us